Terbutaline is a generic version of the name-brand drugs Brethine and Bricanyl. It is commonly used "off label" to stop pre-term labor, prolong pregnancy and prevent premature birth. About 1 million women are treated with terbutaline and related drugs every year for this purpose.
Terbutaline is actually an asthma drug and it’s use to control pre-term labor is highly controversial. Some medical professionals contend that the drug is dangerous while others say it is no more effective at prolonging labor than a placebo. The US Food and Drug Administration has not approved uses of terbutaline for anything other than controlling asthma.
Several recent studies have raised concerns that the drug may have a profound, negative impact on an unborn baby’s brain development because it can cause overstimulation of certain brain activity. This overstimulation could lead to autism, particularly in twins.
Further, the study’s findings suggest that exposure to drugs like terbutaline early in development might leave the brains of children especially susceptible to damage from environmental chemicals like pesticides.
As a result, when mothers are given terbutaline during pregnancy, even those children who escape the trauma of autism at birth could remain at risk for the condition for years after birth.
Cappolino Dodd Krebs is currently investigating cases of fraternal twins diagnosed with autism who’s mother was treated with terbutaline during pregnancy. If you or someone you love has autistic fraternal twins, please contact us for professional insight.